Transcatheter Heart Valve Replacement Market Analysis

Transcatheter Heart Valve Replacement Market Analysis

Transcatheter mitral valve repair & replacement segment is poised to expand at 23.6% CAGR through 2026 owing to the increasing incidences of mitral regurgitation across the globe. Mitral regurgitation is the most prevalent abnormality worldwide and its prevalence is increasing in the geriatric population. According to a study by the National Center for Biotechnology Information (NCBI), approximately 1.3 million adults in the U.S. currently suffer from mitral regurgitation. Therefore, transcatheter mitral valve replacement (TMVR) has emerged as an alternative therapeutic option for the treatment of mitral regurgitation in patients with prohibitive or high surgical risk and is driving the demand for transcatheter mitral valves. Moreover, the growing incidences of ischemic functional secondary mitral regurgitation and degenerative primary mitral regurgitation is further uplifting the demand for transcatheter mitral valves.

Transapical approach segment is anticipated to register 18% growth rate during the forecast timeframe propelled by the antegrade approach and provision of easy wiring with excellent controllability. The transapical approach enables easier accessibility to the aortic valve with easier controllability. Therefore, this approach is widely used in transcatheter aortic valve implementation (TAVI) and transcatheter mitral valve replacement procedures. In addition, transapical approach is easier to perform, maintains proximity to the target and enables a controlled implantation.

To get key market trends

  Download Free Sample

Hospitals segment size in the transcatheter heart valve replacement market was more than USD 3,652 million in 2019 due to the reimbursement received by the hospitals for valve replacement procedures as these procedures are expensive. Moreover, presence of skilled surgeons in hospital setting and availability of technologically advanced equipment and tools utilized in heart valve replacement procedures is augmenting the number of people opting for transcatheter heart valve replacement in hospitals.

Aortic valvular heart disease segment revenue was around USD 4,818 million in 2019 on account of rising incidences of aortic valvular heart disease. Moreover, growing geriatric population is also contributing to the increasing prevalence of aortic valvular heart disease. This is because the people over the age of 70 years are prone to aortic stenosis. In addition, around 15% of the patients with 40 years or above age are prone to suffer from aortic stenosis due to bicuspid aortic valve. Aortic stenosis is the second most common valvular lesion in the U.S.

<

U.S. dominated the North America transcatheter heart valve replacement market and held largest revenue share of around 88% in 2019 attributed to the growing prevalence of heart valve disorders in the U.S. According to a published article, approximately, 5 million people in the U.S. are diagnosed with heart valve disorder every year. Therefore, more than 80,000 aortic valve replacement (AVR) procedures are performed each year in the country. As a result, the demand for transcatheter heart valves in the U.S. is consistent. Favorable reimbursement scenario by the Centers for Medicare & Mediclaim pertaining to transcatheter heart valve replacement procedures is additionally fueling the number of people undergoing valve replacement. Moreover, growing number of transcatheter aortic valve replacement centers (TAVR) centers in the U.S. is uplifting the adoption of AVR procedures in the country.

Germany transcatheter heart valve replacement market value in 2019 was over USD 383 million due to the improved healthcare infrastructure in the country and rising prevalence of aortic stenosis in geriatric population. According to a published report, more than 25,000 TAVR procedures are currently performed in Germany. The country has been leading in the clinical adoption of transcatheter aortic valve implantation (TAVI) and introduced TAVR routinely is some selected centers in 2006. Moreover, German Aortic Valve Registry, established in 2011, is engaged in providing data for reimbursement. Moreover, presence of highly skilled interdisciplinary team of heart specialists in the country is contributing to an increased number of transcatheter heart valve replacement procedures in the country.